Leadership cements the foundation for increasing the efficient and effective delivery of treatment plans in project management and performance improvement programs at Sparrow Hospital in Lansing, Mich.
Leadership cements the foundation for increasing the efficient and effective delivery of treatment plans in project management and performance improvement programs at Sparrow Hospital in Lansing, Mich. Leadership is the cornerstone at every level, beginning with the executive sponsors, project managers, physicians, nurses, respiratory therapists, pharmacists, discharge planners, case managers and social workers. Stakeholders are critical to program success not only because they implement the protocols from admission to release but also because they play an important role in spreading the philosophy of this approach to healthcare. A physician champion within each group provides additional leadership by promoting the program and securing peer support.
The requirements for successful implementation of program management in healthcare are simple but not easy. The climate must be right and executive sponsors must be able to adapt their plan or adjust the climate. Physicians must buy into and sell their colleagues on the program. Everyone must be committed to following the protocols that make up the various programs and meet the standards of care. The organization must be committed to seeing the programs through from the moment of inception.
The key to performance improvement is receptivity, says Dennis Swan, CEO of Sparrow Health System. "You have to start with an environment of openness to new ideas and strategies, and you need strong physician leadership to make this work. You look for those who say, 'I will try this in my own practice.'"
Project Manager Mark Wehner, PMP, RRT, a respiratory therapist at Sparrow believes that it requires patience to allow enough time to fairly judge the program's success. "Performance improvement takes time, and it requires making adjustments," Wehner says.
There are two challenges in standardizing care. "One is to build expectations that a certain area of treatment will be approached in a certain way and to build consensus that that will happen," says Larry Rawsthorne, MD, vice president of medical affairs at Sparrow. "This requires letting go of one's clinical idiosyncrasies, which may or may not be evidence-based. To surrender the way you do things requires a change in approach to care.
"The second challenge is to develop the institutional ability to understand when an approach is not appropriate for a particular patient, for example, special variance may be required because of other medical issues," Dr. Rawsthorne says.
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
Air Pollution May Negatively Affect Male Reproductive Health
November 30th 2023A potential mechanism by which air pollutants may affect reproductive health is by endocrine disruption. Air pollutants are made up of mixtures of particulate matter that may include endocrine disruptors, such as polycyclic aromatic hydrocarbons (PAHs) and heavy metals.
Read More
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More